It is quite possible you haven’t noticed that 2025 is the International Year of Quantum Science and Technology — or IYQ, for short. Yet it is something hordes of scientists are very excited about, as is UNESCO, which came up with the idea.
“Achieving successful medical technology commercialization and market access requires a highly sophisticated ecosystem of partners, and we have assembled the world’s leading regulatory, technology, product development, clinical and market access service providers to address the entire lifecycle of a medtech startup,” said Paul Grand, founder and CEO of MedTech Innovator.
Cambridge Consultants head of aerospace Stewart Marsh joined a panel at The 2025 SmallSat Symposium on February 4, and warned that operators had to be aware that changing the model, for any reason, meant risk and knowing how to mitigate those risks was crucial.
Capgemini announced on Monday that it had made a breakthrough in generative biology, also known as engineering or synthetic biology, at its deep tech powerhouse Cambridge Consultants. The news was been widely picked up, including by PharmaTimes
Capgemini’s new patent-pending generative AI uses specialized large language models to accelerate the bioeconomy and biotechnology sector by drastically reducing the time and resources needed for research and development.
What will it take for businesses to become “quantum ready”, and what obstacles will they need to overcome to secure their quantum future?